Pentasa tablets approved for once daily use

Pentasa (mesalazine) 500mg slow-release tablets have been licensed for once daily administration in the maintenance therapy of mild to moderate ulcerative colitis.

All oral formulations of Pentasa are now approved for once daily dosing in a maintenance setting.

View Pentasa drug record

Further information: Ferring

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Male clinician in white coat showing female patient how to use IQoro device.

Training device for reflux and dysphagia available on NHS

A neuromuscular training device for patients with reflux-based...

Deleted products - live tracker

EXCLUSIVE TO SUBSCRIBERS See the latest products removed...

New and deleted indications - live tracker

EXCLUSIVE TO SUBSCRIBERS See the latest changes to...

Drug shortages - live tracker

Use our constantly updated shortages tracker to check...